Procalcitonin (CLIA) - ARCSA Registration da54da110ad39a1d5a1aabfa28e001d3
Access comprehensive regulatory information for Procalcitonin (CLIA) in the Ecuador medical device market through Pure Global AI's free database. This II medical device is registered under ARCSA ID da54da110ad39a1d5a1aabfa28e001d3 and manufactured by SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.. The device was registered on April 18, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
II
da54da110ad39a1d5a1aabfa28e001d3
Procalcitonin (CLIA)
ARCSA ID: da54da110ad39a1d5a1aabfa28e001d3
Device Classification
Risk Class
II
Product Type
In Vitro Diagnostic
Brand Name
MINDRAY
Commercial Name
19-132 IVD Reagents/Assay, Immunoassay, Bone Metabolism Hormone
Registration Information
Analysis ID
da54da110ad39a1d5a1aabfa28e001d3
Registration Date
April 18, 2023
Expiration Date
April 18, 2028
Product Use
QUANTITATIVE DETERMINATION OF PROCALCITONIN (PCT) IN HUMAN PLASMA OR SERUM.
Manufacturer
City
SHENZHEN
Country
CHINA
Address
MINDRAY BUILDING, KEJI 12TH ROAD SOUTH, HI-TECH INDUSTRIAL PARK,NANSHAN, SHENZHEN 518057, PR. CHINA
Product Owner
Name
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Country
CHINA
Authorized Representative